Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbohydrate-digesting enzymes are a group of hydrolases responsible for breaking down complex carbohydrates into absorbable monosaccharides. The process begins in the mouth with **salivary amylase**, which starts hydrolyzing starches into smaller oligosaccharides[5][6][7]. In the small intestine, **pancreatic amylase** continues this process by further degrading starches to maltose and dextrins[1][2][6]. Final digestion occurs at the brush border membrane of enterocytes via specific disaccharidases—**maltase**, **sucrase**, **lactase**, and **isomaltase**—which convert disaccharides like maltose, sucrose, lactose, and limit dextrins into their constituent monosaccharides such as glucose, fructose, and galactose[2][5][6]. These enzymes are essential for nutrient absorption; deficiencies or inhibition can lead to malabsorption syndromes or be therapeutically targeted in conditions like diabetes mellitus using drugs such as acarbose or miglitol that inhibit these enzymes to slow carbohydrate absorption[7]. However "Carbohydrate-digesting enzyme" is not a single molecule but rather refers collectively to several distinct digestive enzymes. For structured data purposes it is preferable to specify individual targets such as "Salivary amylase," "Pancreatic amylase," or specific brush border disaccharidases ("Lactase," "Sucrase," etc.), since each has unique properties and clinical relevance. Therefore this entry is considered too broad/unspecific for canonical target mapping[1][2][5].
Inhibition of carbohydrate-digesting enzymes to delay glucose absorption and reduce postprandial blood sugar spikes (as with acarbose and miglitol)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbohydrate-digesting enzyme.